ClinicalTrials.gg
Not yet recruitingNCT07681531Updated Jul 2, 2026

Laser Ablation Versus Conventional Fistulectomy for Uncomplicated Perianal Fistula

An interventional study of Laser ablation and Conventional Open Fistulectomy in Perianal Fistula and Anal Fistula, sponsored by PNS Hafeez - Naval Hospital. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-07-02.

Sponsored by PNS Hafeez - Naval Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

This randomized controlled trial aims to compare conventional open fistulectomy and laser ablation in the treatment of uncomplicated perianal fistula. The study will evaluate postoperative recovery time and recurrence rates between the two procedures. A total of 72 patients with uncomplicated perianal fistula will be randomly assigned to either conventional open fistulectomy or laser ablation and followed for six months after surgery.

Read the detailed description

Perianal fistula is a common anorectal condition that usually requires surgical treatment. Conventional open fistulectomy has been widely used because of its established effectiveness; however, it may be associated with prolonged recovery. Laser-assisted anal fistula surgery is a newer minimally invasive technique that may offer faster postoperative recovery and less tissue damage.

Published studies have reported conflicting results regarding the superiority of either technique in terms of postoperative recovery and recurrence. Therefore, this randomized controlled trial is being conducted to compare conventional open fistulectomy and laser ablation in patients with uncomplicated perianal fistula.

The study will be conducted at the Department of Surgery, PNS Hafeez Hospital, Islamabad. Seventy-two patients aged 18 to 55 years with uncomplicated perianal fistula will be enrolled and randomized in a 1:1 ratio by paper lottery method into two groups. Group C will undergo conventional open fistulectomy, and Group L will undergo laser-assisted anal fistula surgery.

The primary outcome measures are postoperative recovery time and recurrence of perianal fistula within six months after surgery. Patients will be followed at two weeks and six months postoperatively. The findings of this study may help determine the optimal surgical approach for uncomplicated perianal fistula.

02

Conditions studied

  • Perianal Fistula
  • Anal Fistula

Browse trials for

Keywords

  • Perianal fistula
  • Anal fistula
  • Laser ablation
  • Laser-assisted anal fistula surgery
  • FiLaC
  • Fistulectomy
  • Conventional surgery
  • Randomized controlled trial
03

In context

Rectal Fistula

169 studies on the registry are indexed under Rectal Fistula; 45 are open to participants now.

This study's planned enrollment of 72 is close to the median of 66 across 115 interventional studies indexed under Rectal Fistula.

Browse Rectal Fistula studies →

Lead sponsor

PNS Hafeez - Naval Hospital is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 55 years.
  • Male and female patients.
  • Scheduled for surgical treatment of uncomplicated perianal fistula.
  • Single fistula tract.
  • Less than 30% involvement of the external anal sphincter.
  • Penetration of tract limited to subcutaneous tissue.

Exclusion criteria

Exclusion Criteria:

  • Recurrent fistula.
  • Complex fistula.
  • History of gut .
  • History of inflammatory bowel disease.
  • Patients unfit for anesthesia.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Laser Ablation

    Patients will undergo laser-assisted anal fistula surgery according to institutional protocol.

    Procedure: Laser ablation · Procedure: Conventional Open Fistulectomy

  • Active comparator
    Conventional Open Fistulectomy

    Patients will undergo conventional open fistulectomy according to institutional protocol.

    Procedure: Laser ablation · Procedure: Conventional Open Fistulectomy

Interventions

  • ProcedureLaser ablation

    Laser-assisted anal fistula surgery for uncomplicated perianal fistula.

  • ProcedureConventional Open Fistulectomy

    Conventional open fistulectomy for uncomplicated perianal fistula.

06

What researchers measure

Primary outcomes

  1. Post operative recovery time

    Time from the end of surgery until return to work with no residual anal pain and no bleeding or discharge.

    Time frame: 2 weeks after surgery

  2. Recurrance of perianal fistula

    Reappearance of perianal fistula after surgery.

    Time frame: 6 months after surgery

07

Study locations

1 site
  • PNS Hafeez Naval Hospital
    Islamabad, 44400, Pakistan
08

References and documents

Individual participant data

Plan to share: Undecided — The investigators have not yet determined whether de-identified individual participant data will be shared with other researchers. Any future data sharing will be subject to institutional policies, ethical approval, and participant confidentiality requirements.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Mar 2027, 8 months later.

Of 53 non-industry interventional studies with no phase under Rectal Fistula, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 36. This study's planned 8 months is below that.

Counting every sponsor, half of 57 studies reached it within 27 months; a quarter within 11 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 26, 2026
First posted
Jul 2, 2026
StartEst.
Jul 1, 2026
Primary completionEst.
Mar 31, 2027
CompletionEst.
Mar 31, 2027
Last update
Jul 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07681531
Lead sponsor
PNS Hafeez - Naval Hospital
Responsible party
Fahad Raza Ansari (FCPS General Surgery Resident Department of Surgery PNS Hafeez Hospital, Islamabad, PNS Hafeez - Naval Hospital) — Principal investigator
First posted
Jul 2, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Jul 2, 2026

Study contacts

Fahad Raza Ansari, MBBS, FCPS Resident
Contact
sunny_slf@hotmail.com
+923215550121

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion